Hemant Surgical Industries Limited IPO

25 May 2023|

1 min read |

by ICICI Securities Team

About the Company

Hemant Surgical Industries Limited is involved in the business of manufacturing, importing, assembling, and marketing a comprehensive portfolio of medical equipments and disposables that are imported from countries like Japan, China, France and Australia.

Products

The company offers equipment and disposables related to:

Renal Care
Cardiovascular disease
Respiratory disease
Critical Care and Radiology
Surgery

Business Model

Hemant Surgical Industries Limited is a B2B company. They import, assemble and market products to healthcare facilities.

IPO details

IPO Date	May 24, 2023–May 26, 2023
Price	₹85–₹90 per share
Lot Size	1600 Shares

IPO Objective

The Company intends to utilize the Proceeds on:

Funding capital expenditure towards installation of additional plant and machinery

Funding to meet working capital requirements

General Corporate Purpose

Company Financials

Particulars	Year ended 31.03.2023	Year ended 31.03.2022	Year ended 31.03.2021
Net worth (in lakhs)	2,359.90	1,314.78	853.38
Total Borrowings (in lakhs)	711.92	973.80	1446.35
Total Revenues (in lakhs)	11,149.68	10,577.02	6,065.19
Basic Earnings per share	10.28	8.96	2.22

Major Business-Related Risk

There are outstanding legal proceedings involving the Company and Directors. Any adverse decision in such proceeding may have a material adverse effect on the business, results of operations and financial condition.
The margins in this business are traditionally low with a lot of competition.

How to apply for a Quick IPO on ICICIdirect

➢ Select IPO

Go to the IPO section, select the IPO you want to apply from the list and click on ‘Apply’.

➢ Fill in the required details

Fill in the quantity of the number of shares you want to buy. To apply at maximum price, check the cut-off price box and amount is auto calculated. If you want to apply at some other price within the price band, then you can enter the price manually by clicking on “Add bid” option.

➢ Confirm your request

Click on proceed to confirm the order. You can view the placed order under “order book”. If you are applying using UPI, check the A/C and UPI details before clicking on proceed. You will get an UPI link by which payment can be made.

Disclaimer

ICICI Securities Limited has its registered office at ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. The non-broking products / services like iLearn and Financial Learning are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism. iLearn is not an exchange traded product/service of ICICI Securities Ltd. All disputes with respect to the activity on the platform would not have access to Exchange investor redressal or Arbitration mechanism.

ICICI Securities Ltd. is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. ICICI Securities Ltd. is a SEBI registered with SEBI as a Research Analyst vide registration no. INH000000990. Name of the Compliance officer (broking): Mr. Atul Agrawal, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com Investments in securities markets are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. ICICI Securities Ltd. and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. AMFI Regn. No.: ARN-0845. PFRDA registration numbers: POP no -05092018. ICICI Securities Ltd. acts as a Composite Corporate agent having registration number -CA0113. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully. Please note, Mutual Fund, Corporate Fixed Deposits, Bonds, Alternate investment funds, Tax planning, Succession planning, NPS, IPO, Investment Advisory and Loans related services are not Exchange traded products and ICICI Securities Ltd. is acting as a distributor to solicit these products. Please note, Insurance related services are not Exchange traded products and ICICI Securities Ltd. is acting as a corporate agent to solicit these products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The non-broking products / services like Research, etc. are not exchange traded products / services and all disputes with respect to such activities would not have access to Exchange investor redressal or Arbitration mechanism. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.